Astrana Health (NASDAQ:ASTH) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Astrana Health (NASDAQ:ASTH) issued its earnings results on Tuesday. The company reported $0.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.01), Briefing.com reports. The company had revenue of $404.36 million during the quarter, compared to analysts’ expectations of $413.84 million. Astrana Health had a return on equity of 11.52% and a net margin of 4.49%. The company’s revenue for the quarter was up 19.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.42 EPS. Astrana Health updated its FY24 guidance to $1.28 to $1.52 EPS.

Astrana Health Trading Up 0.4 %

NASDAQ ASTH opened at $38.09 on Thursday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.11 and a current ratio of 2.11. Astrana Health has a 12 month low of $28.86 and a 12 month high of $45.71. The company has a market cap of $2.13 billion, a PE ratio of 28.86, a price-to-earnings-growth ratio of 1.20 and a beta of 1.12. The business’s 50 day moving average price is $40.24.

Analyst Upgrades and Downgrades

ASTH has been the topic of a number of recent research reports. Stifel Nicolaus lowered their target price on Astrana Health from $50.00 to $45.00 and set a “buy” rating on the stock in a report on Wednesday. Jefferies Financial Group initiated coverage on shares of Astrana Health in a report on Monday, February 26th. They set a “buy” rating and a $50.00 target price for the company. Finally, Truist Financial boosted their price objective on shares of Astrana Health from $41.00 to $44.00 and gave the company a “hold” rating in a research report on Friday, March 1st.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.